APA

Van Cutsem E., van de Velde H., Karasek P., Oettle H., Vervenne W. L., Szawlowski A., Schoffski P., Post S., Verslype C., Neumann H., Safran H., Humblet Y., Perez Ruixo J., Ma Y. & Von Hoff D. (20040507). Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Van Cutsem E, van de Velde H, Karasek P, Oettle H, Vervenne W L, Szawlowski A, Schoffski P, Post S, Verslype C, Neumann H, Safran H, Humblet Y, Perez Ruixo J, Ma Y and Von Hoff D. 20040507. Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Van Cutsem E., van de Velde H., Karasek P., Oettle H., Vervenne W. L., Szawlowski A., Schoffski P., Post S., Verslype C., Neumann H., Safran H., Humblet Y., Perez Ruixo J., Ma Y. and Von Hoff D. (20040507). Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Van Cutsem E, van de Velde H, Karasek P, Oettle H, Vervenne W L, Szawlowski A, Schoffski P, Post S, Verslype C, Neumann H, Safran H, Humblet Y, Perez Ruixo J, Ma Y and Von Hoff D. Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20040507.